Here's a text-heavy but still brief summary "slidedoc" of what I would consider to be the core principles of managing locally advanced, or stage III, non-small cell lung cancer (NSCLC). This is a heterogeneous population that accounts for about 40% of the patients newly diagnosed with NSCLC, with some having far more extensive and bulky disease than others.  Though individual treatment recommendations should be made by the physicians directly reviewing the details of a patient's case, the key principles still govern the overall plan.

The hyperlinks are to this earlier Slidedoc: http://www.slideshare.net/JackWestMD/treating-invisible-disease-grace

And here's the printable pdf file of the slides: Core Principles of Managing Locally Advanced NSCLC

As always, I hope it's helpful, and I welcome you to add your questions, comments, objections, or expressions of joy here.